References
- Peerless SJ, Ishikawa R, Hunter IG, Peerless MJ. Protective effect of Fluosol-DA in acute cerebral ischema. Stroke 1981; 12: 558–563
- Glogar DH, Kloner RZ, Muller J, DeBoer LWV, Braunwald E, Clark LC, Jr. Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science 1981; 211: 1439–1441
- Teicher BA, Lazo J S, Merrill WW, Filderman AE, Rose CM. Effect of Fluosol-DA/02 on the antitumor activity and pulmo-nary toxicity of bleomycin. Cancer Chemother Pharmacol 1986; 18: 213–218
- Hiraga S, Klubes P, Owens ES, Cysyk RL, Blasberg RG. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange. Cancer Res 1987; 47: 3296–3302
- Song CW, Lee I, Hasegawa T, Rhee JG, Levitt SH. Increase in pO# and radiosensitivity of tumors by Fluosol-DA (20%) and ca#ogen. Cancer Res 1987; 47: 442–446
- Jaffe CC, Wohlgelernter D, Highman HA, Cleman M. Oxygena-ted Fluosol DA-20% distal infusion during coronary angioplasty protects myocardial function. Prog Clin Biol Res 1986; 211: 21–27
- Clark LC, Jr, Misrahy G, Fox RP. Chronically implanted polarographic electrodes. J Appl Physiol 1958; 13: 85–91
- Clark LC, Jr. Chronically implanted platinum elec-trodes for continuous electrochemical monitoring in conscious rabbits. In preparation 1987
- Clark LC, Jr., Noyes LK, Grooms TA, Moore MS. Rapid micromeasurement of lactate in whole blood. Crit Care Med 1984; 12: 461–464
- Clark LC, Jr., Kaplan S, Beccatini F. The physiology of synthetic blood. J Thorac Cardiovasc Surg 1970; 60: 757–773
- Clark LC, Jr. Theoretical and practical considerations of fluorocarbon emulsions in the treatment of shock. Pathophysiology of Shock, Anoxia and Ischemia, RA Cowley. Williams & Wilkens, Baltimore 1982; 507–522
- Gould SA, Rosen AL, Sehgal LR, Sehgal HL, Langdale LA, Krause LM, Rise CL, Chamberlain WH, Moss GS. Fluosol-DA as a red-cell substitute in acute anemia. N Engl J Med 1986; 314: 1653–1656
- Blood Policy & Technology. Chapter 6. Alternative technologies. U. S. Congress Office of Technology Assessment, Washington, DC January, 1985, OTA-H-260
- Hermoni Y, Millard RW, Gabel M. Fluosol-DA as a red-cell substitute in acute anemia. (Letter) New Engl M Med 1986; 315: 1677–1678